Safety And Therapeutic Measures Of Transcranial Cathodal Direct

$Safety And Therapeutic Measures Of Transcranial Cathodal Direct Current Stimulation (Tdcs) In Patients With Refractory Focal Epilepsy$

Recruiting

9 years - 99 years

All

Phase 3

8 participants needed

1 Location

Brief description of study

The study aims to evaluate the safety, tolerability and efficacy of repeated, daily sessions of transcranial cathodal direct current simulation (tDCS) as administered by the10 STARSTIM (tDCS) device in 10 consecutive days of in-office treatment sessions.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions: Epilepsy
Age: 9 years - 99 years
Gender: All

Male or Female, Age 9 or older, Diagnosis of epilepsy with focal seizures

Updated on 04 Aug 2024. Study ID: 849985

Find a site

Your Information has been sent successfully.

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.

Would you like to be notified about other trials? Sign up for Patient Notification Services.

Send a message

Enter your contact details to connect with study team

Primary Contact

First name*

Last name*

Email*

Phone number*

Preferred way of contact

Race

Ethnicity

Are you Healthy Volunteer

Are you comfortable with the informed consent process?

Yes

Other language

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).

Safety And Therapeutic Measures Of Transcranial Cathodal Direct Current Stimulation (Tdcs) In Patients With Refractory Focal Epilepsy

Brief description of study

Eligibility of study

Find a site

Interested in the study